Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.8895
Delayed Data
As of May 21
 -0.0105 / -1.17%
Today’s Change
0.72
Today|||52-Week Range
2.26
-12.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues3.9M4.2M4.4M4.8M
 
 
 
 
 
Cost of Goods Sold1.7M2.0M1.6M2.5M
 
 
 
 
 
Depreciation And Amortization965.0K876.0K876.0K855.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.2M1.3M1.9M1.4M
 
 
 
 
 
General Expenses4.8M4.4M5.0M4.7M
 
 
 
 
 
Research And Development413.0K483.0K259.0K501.0K
 
 
 
 
 
Total Operating Expenses7.5M7.3M7.5M8.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-3.1M-3.1M-3.2M
 
 
 
 
 
Extraordinary Charge-2.7M0.00-174.0K0.00
 
 
 
Interest Expense On Debt216.0K40.0K0.000.00
 
 
 
Other Expenses-8.0K-294.0K-1.7M111.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.6M-3.4M-5.0M-3.1M
 
 
 
 
 
Income Taxes-301.0K-42.0K-55.0K-6.0K
 
 
 
 
 
Discontinued Operations-54.0K71.0K-51.0K-50.0K
 
 
 
 
 
Net Income-6.3M-3.3M-5.0M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M22.0M26.9M27.9M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M22.0M26.9M27.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.65-$0.15-$0.19-$0.11
 
 
 
 
 
EPS Diluted-$0.65-$0.15-$0.19-$0.11